Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

• Main Authors: Ashley Munchel (Author), Chimen Kesserwan (Author), Heather J. Symons (Author), Leo Luznik (Author), Yvette L. Kasamon (Author), Richard J. Jones (Author), Ephraim J. Fuchs (Author)
• Format: Book
• Published: MDPI AG, 2011-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Allogeneic stem cell transplantation (SCT) from an HLA-haploidentical relative provides a potentially curative treatment option for hematologic malignancies patients who lack a suitably HLA-matched donor. The greatest challenge to performing HLA-haploidentical SCT has been high rates of graft failur...